View in EDS HTML Full Text PDF Full Text

The Role of CELMoD Agents in Multiple Myeloma.

Saved in:
Bibliographic Details
Title: The Role of CELMoD Agents in Multiple Myeloma.
Authors: van de Donk NWCJ; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands., Bahlis NJ; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada., Pawlyn C; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK., Gay F; Department of Molecular Biotechnology and Health Science, Division of Hematology, University of Torino, AOU Città della Salute e della Scienza di Torino, Turin, Italy., Mateos MV; University Hospital of Salamanca/IBSAL, Salamanca, Spain., Weisel K; University Medical Center Hamburg-Eppendorf, Hamburg, Germany., Lonial S; Winship Cancer Institute, Emory University, Atlanta, GA, USA., Richardson PG; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
Source: OncoTargets and therapy [Onco Targets Ther] 2025 Aug 27; Vol. 18, pp. 921-933. Date of Electronic Publication: 2025 Aug 27 (Print Publication: 2025).
Publication Type: Journal Article; Review
Journal Info: Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101514322 Publication Model: eCollection Cited Medium: Print ISSN: 1178-6930 (Print) Linking ISSN: 11786930 NLM ISO Abbreviation: Onco Targets Ther Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40901494
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: The Role of CELMoD Agents in Multiple Myeloma.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22van+de+Donk+NWCJ%22">van de Donk NWCJ</searchLink>; Department of Hematology, Cancer Center Amsterdam, Amsterdam University Medical Center, Vrije Universiteit Amsterdam, Amsterdam, Netherlands.<br /><searchLink fieldCode="AU" term="%22Bahlis+NJ%22">Bahlis NJ</searchLink>; Arnie Charbonneau Cancer Institute, University of Calgary, Calgary, AB, Canada.<br /><searchLink fieldCode="AU" term="%22Pawlyn+C%22">Pawlyn C</searchLink>; The Institute of Cancer Research, London, UK.; The Royal Marsden NHS Foundation Trust, London, UK.<br /><searchLink fieldCode="AU" term="%22Gay+F%22">Gay F</searchLink>; Department of Molecular Biotechnology and Health Science, Division of Hematology, University of Torino, AOU Città della Salute e della Scienza di Torino, Turin, Italy.<br /><searchLink fieldCode="AU" term="%22Mateos+MV%22">Mateos MV</searchLink>; University Hospital of Salamanca/IBSAL, Salamanca, Spain.<br /><searchLink fieldCode="AU" term="%22Weisel+K%22">Weisel K</searchLink>; University Medical Center Hamburg-Eppendorf, Hamburg, Germany.<br /><searchLink fieldCode="AU" term="%22Lonial+S%22">Lonial S</searchLink>; Winship Cancer Institute, Emory University, Atlanta, GA, USA.<br /><searchLink fieldCode="AU" term="%22Richardson+PG%22">Richardson PG</searchLink>; Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA, USA.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101514322%22">OncoTargets and therapy</searchLink> [Onco Targets Ther] 2025 Aug 27; Vol. 18, pp. 921-933. <i>Date of Electronic Publication: </i>2025 Aug 27 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Review
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Dove+Medical+Press%22">Dove Medical Press </searchLink><i>Country of Publication: </i>New Zealand <i>NLM ID: </i>101514322 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Print <i>ISSN: </i>1178-6930 (Print) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2211786930%22">11786930 </searchLink><i>NLM ISO Abbreviation: </i>Onco Targets Ther <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40901494
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.2147/OTT.S398118
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 921
    Titles:
      – TitleFull: The Role of CELMoD Agents in Multiple Myeloma.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: van de Donk NWCJ
      – PersonEntity:
          Name:
            NameFull: Bahlis NJ
      – PersonEntity:
          Name:
            NameFull: Pawlyn C
      – PersonEntity:
          Name:
            NameFull: Gay F
      – PersonEntity:
          Name:
            NameFull: Mateos MV
      – PersonEntity:
          Name:
            NameFull: Weisel K
      – PersonEntity:
          Name:
            NameFull: Lonial S
      – PersonEntity:
          Name:
            NameFull: Richardson PG
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 27
              M: 08
              Text: 2025 Aug 27
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-print
              Value: 1178-6930
          Numbering:
            – Type: volume
              Value: 18
          Titles:
            – TitleFull: OncoTargets and therapy
              Type: main
ResultId 1